Vertex Global HC Fund II Pte. Ltd. - 24 Jun 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
10%+ Owner
Signature
/s/ Wing Shing Lee, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
24 Jun 2021, 18:33:31 UTC
Next filing
29 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELEV Series A Convertible Preferred Stock 24 Jun 2021 Common Stock 1,656,577 Direct F1
holding ELEV Series B Convertible Preferred Stock 24 Jun 2021 Common Stock 401,065 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock will automatically convert into Common Stock immediately on a 4.225582-for-one basis (4.225582 shares of preferred stock will convert into 1 share of Common Stock) prior to the closing of the Issuer's initial public offering, and has no expiration date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney